カテゴリ： FactMR, 世界, 医療/バイオ

制酸薬のグローバル市場2023～2033：プロトンポンプ阻害剤、H2アンタゴニスト、酸性中和剤

■ 英語タイトル：Antacids Market By Drug Class (Proton Pump Inhibitors, H2 Antagonists, Acid Neutralizers), By Formulation (Tablets, Liquid, Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Region – Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23MA039）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23MA039
■ 発行日：2023年4月12日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[制酸薬のグローバル市場2023～2033：プロトンポンプ阻害剤、H2アンタゴニスト、酸性中和剤]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社の本市場調査レポートは、予測期間（2023年〜2033年）における世界の制酸薬市場について、市場状況や動向を推測した資料です。本レポートは、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、薬物クラス別（プロトンポンプ阻害剤、H2アンタゴニスト、酸性中和剤）分析、製剤別（錠剤、液体、粉末、その他）分析、流通チャネル別（病院薬局、小売薬局、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況などの項目を掲載しています。また、本書内には、 Bayer AG、Boehringer Ingelheim GmbH、Dr. Reddy’s Laboratories Ltd.など、主要企業情報を含んでいます。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・世界の制酸薬市場規模：薬物クラス別
- プロトンポンプ阻害剤の市場規模
- H2アンタゴニストの市場規模
- 酸性中和剤の市場規模
・世界の制酸薬市場規模：製剤別
- 錠剤型制酸薬の市場規模
- 液体型制酸薬の市場規模
- 粉末型制酸薬の市場規模
- その他製剤の市場規模
・世界の制酸薬市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- その他チャネルの市場規模
・世界の制酸薬市場規模：地域別
- 北米の制酸薬市場規模
- 中南米の制酸薬市場規模
- ヨーロッパの制酸薬市場規模
- アジア太平洋の制酸薬市場規模
- 中東・アフリカの制酸薬市場規模
・競争状況

本書には、各参入企業の製品ポートフォリオ、主要戦略及び包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスにより提供されます。したがって、レポートの読者に実用的洞察を提示し、熟考して市場状況を提供し、制酸薬における競争レベルを予想するのに活用できます。

ANTACIDS Market – Scope of Report

A recent study by Fact.MR on the ANTACIDS market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering Antacids.
The study also provides the dynamics responsible for influencing the future status of the ANTACIDS market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the ANTACIDS market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of ANTACIDS across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of ANTACIDS during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for ANTACIDS are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global ANTACIDS market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the ANTACIDS market during the forecast period.
Country-specific valuation on demand for ANTACIDS has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of XYZ, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering ANTACIDS has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the ANTACIDS domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Market Value (US$ Mn) Forecast, 2023 – 2033

    4.5. Porter’s Five Force Analysis

    4.6. Value Chain Analysis

    4.7. Market Outlook

5. Global Market Analysis and Forecasts, By Drug Class

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        5.4.1. Proton pump inhibitors

        5.4.2. H2 Antagonist

        5.4.3. Acid neutralizers

    5.5. Market Attractiveness By Drug Class

6. Global Market Analysis and Forecasts, By Formulation

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        6.4.1. Tablet

        6.4.2. Liquid

        6.4.3. Powder

        6.4.4. Others

    6.5. Market Attractiveness By Formulation

7. Global Market Analysis and Forecasts, By Distribution Channel

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        7.4.1. Hospital Pharmacies

        7.4.2. Retail Pharmacies

        7.4.3. Others

    7.5. Market Attractiveness By Distribution Channel

8. Global Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value (US$ Mn) Forecast By Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East and Africa

    8.3. Market Attractiveness By Country/Region

9. North America Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Key Trends

    9.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        9.2.1. Proton pump inhibitors

        9.2.2. H2 Antagonist

        9.2.3. Acid neutralizers

    9.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        9.3.1. Tablet

        9.3.2. Liquid

        9.3.3. Powder

        9.3.4. Others

    9.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        9.4.1. Hospital Pharmacies

        9.4.2. Retail Pharmacies

        9.4.3. Others

    9.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Drug Class

        9.6.2. By Formulation

        9.6.3. By Distribution Channel

        9.6.4. By Country

10. Europe Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Key Trends

    10.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        10.2.1. Proton pump inhibitors

        10.2.2. H2 Antagonist

        10.2.3. Acid neutralizers

    10.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        10.3.1. Tablet

        10.3.2. Liquid

        10.3.3. Powder

        10.3.4. Others

    10.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Others

    10.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        10.5.1. U.K.

        10.5.2. Germany

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Drug Class

        10.6.2. By Formulation

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Asia Pacific Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Key Trends

    11.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        11.2.1. Proton pump inhibitors

        11.2.2. H2 Antagonist

        11.2.3. Acid neutralizers

    11.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        11.3.1. Tablet

        11.3.2. Liquid

        11.3.3. Powder

        11.3.4. Others

    11.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Others

    11.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        11.5.1. India

        11.5.2. China

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Aisa Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Drug Class

        11.6.2. By Formulation

        11.6.3. By Distribution Channel

        11.6.4. By Country

12. Latin America Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Key Trends

    12.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        12.2.1. Proton pump inhibitors

        12.2.2. H2 Antagonist

        12.2.3. Acid neutralizers

    12.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        12.3.1. Tablet

        12.3.2. Liquid

        12.3.3. Powder

        12.3.4. Others

    12.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Others

    12.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Drug Class

        12.6.2. By Formulation

        12.6.3. By Distribution Channel

        12.6.4. By Country

13. Middle East and Africa Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

        13.1.2. Key Trends

    13.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        13.2.1. Proton pump inhibitors

        13.2.2. H2 Antagonist

        13.2.3. Acid neutralizers

    13.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        13.3.1. Tablet

        13.3.2. Liquid

        13.3.3. Powder

        13.3.4. Others

    13.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Others

    13.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        13.5.1. South Africa

        13.5.2. Saudi Arabia

        13.5.3. Rest of MEA

    13.6. Market Attractiveness Analysis

        13.6.1. By Drug Class

        13.6.2. By Formulation

        13.6.3. By Distribution Channel

        13.6.4. By Country

14. Competition Landscape

    14.1. Market Players

    14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        14.2.1. AstraZeneca

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Business Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. Financial Overview

            14.2.1.5. SWOT Analysis

            14.2.1.6. Strategic overview

        14.2.2. Bayer AG

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Business Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. Financial Overview

            14.2.2.5. SWOT Analysis

            14.2.2.6. Strategic overview

        14.2.3. Boehringer Ingelheim GmbH

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Business Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. Financial Overview

            14.2.3.5. SWOT Analysis

            14.2.3.6. Strategic overview

        14.2.4. Dr. Reddy’s Laboratories Ltd.

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Business Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. Financial Overview

            14.2.4.5. SWOT Analysis

            14.2.4.6. Strategic overview

        14.2.5. GlaxoSmithKline plc

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Business Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. Financial Overview

            14.2.5.5. SWOT Analysis

            14.2.5.6. Strategic overview

        14.2.6. Johnson & Johnson

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.6.2. Business Overview

            14.2.6.3. Product Portfolio

            14.2.6.4. Financial Overview

            14.2.6.5. SWOT Analysis

            14.2.6.6. Strategic overview

        14.2.7. Pfizer Inc.

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.7.2. Business Overview

            14.2.7.3. Product Portfolio

            14.2.7.4. Financial Overview

            14.2.7.5. SWOT Analysis

            14.2.7.6. Strategic overview

        14.2.8. Procter & Gamble

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Business Overview

            14.2.8.3. Product Portfolio

            14.2.8.4. Financial Overview

            14.2.8.5. SWOT Analysis

            14.2.8.6. Strategic overview

        14.2.9. Reckitt Benckiser Group plc

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.9.2. Business Overview

            14.2.9.3. Product Portfolio

            14.2.9.4. Financial Overview

            14.2.9.5. SWOT Analysis

            14.2.9.6. Strategic overview

        14.2.10. Sanofi

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.10.2. Business Overview

            14.2.10.3. Product Portfolio

            14.2.10.4. Financial Overview

            14.2.10.5. SWOT Analysis

            14.2.10.6. Strategic overview

        14.2.11. Sun Pharmaceuticals Ltd

            14.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.11.2. Business Overview

            14.2.11.3. Product Portfolio

            14.2.11.4. Financial Overview

            14.2.11.5. SWOT Analysis

            14.2.11.6. Strategic overview

        14.2.12. Takeda Pharmaceutical

            14.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.12.2. Business Overview

            14.2.12.3. Product Portfolio

            14.2.12.4. Financial Overview

            14.2.12.5. SWOT Analysis

            14.2.12.6. Strategic overview

        14.2.13. Valeant Pharmaceuticals International, Inc.

            14.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.13.2. Business Overview

            14.2.13.3. Product Portfolio

            14.2.13.4. Financial Overview

            14.2.13.5. SWOT Analysis

            14.2.13.6. Strategic overview

Table 01: Global Market Size (US$ Mn) Forecast, By Drug Class, 2018–2033

Table 02: Global Market Size (US$ Mn) Forecast, By Formulation, 2023-2033

Table 03: Global Market Size (US$ Mn) Forecast, By Distribution Channel, 2018–2033

Table 04: Global Market (US$ Mn) Forecast, By Region, 2018–2033

Table 05: North America Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 06: North America Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 07: North America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018–2033

Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 09: Europe Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 10: Europe Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 11: Europe Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 12: Europe Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 13: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 14: Asia Pacific Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 17: Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 18: Latin America Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 19: Latin America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018–2033

Table 20: Latin America Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 21: Middle East and Africa Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 22: Middle East and Africa Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 23: Middle East and Africa Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 24: Middle East and Africa Market Size (US$ Mn) Forecast, by Country, 2018–2033

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 酵素阻害剤のグローバル市場展望 2023年-2029年：プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他
  • ペプチド感染症治療薬のグローバル市場2023～2033：テラプレビル、ボセプレビル
  • 大発作治療のグローバル市場2023～2033：第一、第二、第三
  • ペプチドベース心臓血管治療薬のグローバル市場2023～2033：ビバリルジン、エプチフィバチド
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23MA039 )"制酸薬のグローバル市場2023～2033：プロトンポンプ阻害剤、H2アンタゴニスト、酸性中和剤" (英文：Antacids Market By Drug Class (Proton Pump Inhibitors, H2 Antagonists, Acid Neutralizers), By Formulation (Tablets, Liquid, Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Region – Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。